Novartis uses technology to spread awareness
by Pharmacy Life - Published on 10 October 2012
Pharma giant, Novartis, is utilising the ability of YouTube to broadcast a new talk show about advanced breast cancer. The move forms part of Novartis’ continued disease awareness efforts.
The company’s main product in the breast cancer area is Afinitor (everolimus), which gained European approval for advanced breast cancer in July.
The first episode of the ‘Each Voice Counts’ talk show series features four women sharing their stories of life with the disease and comes a week after the relaunch of Novartis’ website: www.globalAdvancedBreastCancerCommunity.org.
The website is a collaboration between Novartis and Inspire, which builds and manages online support communities for patients and carers.
Advanced Breast Cancer Community offers a ‘clearing house’ of tailored information, covering topics such as creating a personal care plan and metastasis and recurrence.